One stock that might be an intriguing choice for investors right now is Akebia Therapeutics, Inc. AKBA. This is because this security in the Medical - Drugs space is seeing solid earnings estimate ...

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo ...

Akebia Therapeutics (AKBA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. As the U.S. market experiences heightened volatility ...

Monday 14 April 2025 twitter linkedin facebook rss User account menu Subscribe ...

Each week, acclaimed columnists Sarah Vine and Peter Hitchens pull apart and debate one 'big idea' on the Mail's new politics show New episodes every Wednesday, listen on Apple, Spotify and ...